PDE5 inhibition ameliorates visceral adiposity targeting the miR-22 / SIRT1 pathway: evidence from the CECSID trial

8 July 2016 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Dysfunctional adipocytes in cardiovascular biology Metabolism / Diabetes mellitus Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science

ESC 365 is supported by

ESC 365 is supported by